173 related articles for article (PubMed ID: 27150875)
1. Two Elderly Patients with Philadelphia Chromosome Positive Mixed Phenotype Acute Leukemia Who Were Successfully Treated with Dasatinib and Prednisolone.
Takata H; Ikebe T; Sasaki H; Miyazaki Y; Ohtsuka E; Saburi Y; Ogata M; Shirao K
Intern Med; 2016; 55(9):1177-81. PubMed ID: 27150875
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Ravandi F; O'Brien SM; Cortes JE; Thomas DM; Garris R; Faderl S; Burger JA; Rytting ME; Ferrajoli A; Wierda WG; Verstovsek S; Champlin R; Kebriaei P; McCue DA; Huang X; Jabbour E; Garcia-Manero G; Estrov Z; Kantarjian HM
Cancer; 2015 Dec; 121(23):4158-64. PubMed ID: 26308885
[TBL] [Abstract][Full Text] [Related]
3. Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era.
Shimizu H; Yokohama A; Hatsumi N; Takada S; Handa H; Sakura T; Nojima Y
Eur J Haematol; 2014 Oct; 93(4):297-301. PubMed ID: 24750307
[TBL] [Abstract][Full Text] [Related]
4. Hypocellular Philadelphia chromosome-positive mixed-phenotype acute leukemia successfully treated with dasatinib: A case report.
Lee S; Fujita K; Wakayama H; Kito Y; Hara T; Tsurumi H
Mol Clin Oncol; 2022 Feb; 16(2):33. PubMed ID: 34987802
[TBL] [Abstract][Full Text] [Related]
5. Dasatinib and low-intensity chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia in a child with Down syndrome.
Hirabayashi S; Hasegawa D; Yamamoto K; Nishimura A; Hosoya Y; Shuo T; Kiyokawa N; Miura M; Takahashi N; Manabe A
Pediatr Blood Cancer; 2019 May; 66(5):e27612. PubMed ID: 30663211
[No Abstract] [Full Text] [Related]
6. Long-term molecular remission in Philadelphia-positive acute lymphoblastic leukemia elderly patient after dasatinib discontinuation.
Vigna E; Gentile M; Giagnuolo G; Recchia AG; Bossio S; De Stefano L; Morelli R; Morabito F
Leuk Lymphoma; 2016 Oct; 57(10):2445-7. PubMed ID: 26879289
[No Abstract] [Full Text] [Related]
7. Spontaneous subdural hematoma in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia with normal platelet count after dasatinib treatment.
Mustafa Ali MK; Sabha MM; Al-Rabi KH
Platelets; 2015; 26(5):491-4. PubMed ID: 25025538
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of patients with development of large granular lymphocyte expansion among dasatinib-treated patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic stem cell transplantation.
Ito Y; Miyamoto T; Kamimura T; Aoki K; Henzan H; Aoki T; Shiratsuchi M; Kato K; Nagafuji K; Ogawa R; Eto T; Iwasaki H; Akashi K
Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e47-54. PubMed ID: 25445469
[TBL] [Abstract][Full Text] [Related]
9. Subdural Hematoma Associated with Dasatinib and Intrathecal Methotrexate Treatment in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia.
Ureshino H; Nishioka A; Kojima K; Kizuka H; Sano H; Shindo T; Kubota Y; Ando T; Kimura S
Intern Med; 2016; 55(18):2703-6. PubMed ID: 27629971
[TBL] [Abstract][Full Text] [Related]
10. [Dasatinib combined with multi-agent chemotherapy regimen in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a prospective study from a single center].
Zhang GJ; Gong XY; Qiu SW; Zhou CL; Liu KQ; Lin D; Liu BC; Wei H; Wei SN; Li Y; Gu RX; Gong BF; Liu YT; Fang QY; Mi YC; Wang Y; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2021 Feb; 42(2):109-115. PubMed ID: 33858040
[No Abstract] [Full Text] [Related]
11. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
12. [Clinical profiles of 7 patients with chronic myelogenous leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia treated with dasatinib].
Hoshino T; Tahara K; Miyawaki K; Hatsumi N; Takada S; Miyawaki S; Sakura T
Rinsho Ketsueki; 2010 Mar; 51(3):181-8. PubMed ID: 20379112
[TBL] [Abstract][Full Text] [Related]
13. Dasatinib monotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia with pulmonary infection in induction remission: A case report and review of the literature.
Zhang C; Luo XQ; Zhang X
Medicine (Baltimore); 2018 Sep; 97(38):e12308. PubMed ID: 30235679
[TBL] [Abstract][Full Text] [Related]
14. 10-year complete remission in a Philadelphia chromosome-positive acute lymphoblastic leukemia patient using imatinib without high-intensity chemotherapy or allogeneic stem cell transplantation.
Fujimaki K; Hattori Y; Nakajima H
Int J Hematol; 2018 Jun; 107(6):709-711. PubMed ID: 29188580
[TBL] [Abstract][Full Text] [Related]
15. Dasatinib-based 2-step induction for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Sugiura I; Doki N; Hata T; Cho R; Ito T; Suehiro Y; Tanaka M; Kako S; Matsuda M; Yokoyama H; Ishikawa Y; Taniguchi Y; Hagihara M; Ozawa Y; Ueda Y; Hirano D; Sakura T; Tsuji M; Kamae T; Fujita H; Hiramoto N; Onoda M; Fujisawa S; Hatta Y; Dobashi N; Nishiwaki S; Atsuta Y; Kobayashi Y; Hayakawa F; Ohtake S; Naoe T; Miyazaki Y
Blood Adv; 2022 Jan; 6(2):624-636. PubMed ID: 34516628
[TBL] [Abstract][Full Text] [Related]
16. [Relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia responding to retreatment with inotuzumab ozogamicin].
Hashimoto H; Tamura Y; Yamada K; Katoh Y; Shimada T; Fujiwara R; Hanamoto H
Rinsho Ketsueki; 2023; 64(8):746-750. PubMed ID: 37673626
[TBL] [Abstract][Full Text] [Related]
17. Targeting BCL-2 and ABL/LYN in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Leonard JT; Rowley JS; Eide CA; Traer E; Hayes-Lattin B; Loriaux M; Spurgeon SE; Druker BJ; Tyner JW; Chang BH
Sci Transl Med; 2016 Aug; 8(354):354ra114. PubMed ID: 27582059
[TBL] [Abstract][Full Text] [Related]
18. Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.
Liu L; Qu Q; Jiao W; Zhang Y; Li X; Ding C; Wu D
Leuk Res; 2015 Aug; 39(8):805-11. PubMed ID: 26021434
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and laboratorial analysis for 15 adult cases of mixed phenotypic acute leukemia with Ph chromosome and/or positive BCR-ABL].
Yan LZ; Chen SN; Ping NN; Wang QR; Liu H; Ding ZX; Zhu MQ; Liang JY; Liu DD; Cen JN; Pan JL; Qiu HY; Sun AN; Wu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1116-20. PubMed ID: 24156417
[TBL] [Abstract][Full Text] [Related]
20. Successful outcome of disseminated Candida tropicalis osteomyelitis on remission induction for childhood Philadelphia chromosome-positive acute lymphoblastic leukaemia-case report.
Xie L; Long Q; Zhou G; Liu S; Wen FQ
Ital J Pediatr; 2021 Feb; 47(1):27. PubMed ID: 33573668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]